Pharmacogenomics in Intracranial Atherosclerotic Disease-CYP2C19 Loss-Of-Function is Associated with Increased Risk of First-time Ischemic Stroke - cns.org

Log In Create an Account

Nidus Wellness and Resilience Residents Foundation Directory

Join CNS

Pharmacogenomics in Intracranial Atherosclerotic Disease-CYP2C19 Loss-Of-Function is Associated with Increased Risk of First-time Ischemic Stroke
Posted : Nov 17, 2020Cerebrovascular Abstract Subspecialty

Abstract Final #: 246

Get Involved

Associated CNS Websites

We use cookies to improve the performance of our site, to analyze the traffic to our site, and to personalize your experience of the site. You can control cookies through your browser settings. Please find more information on the cookies used on our site. Privacy Policy

×